Xiaohui Li
Impact in
-
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Pulmonary Hypertension Research and Treatments 36
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
-
- Renin-Angiotensin System Studies 9
- Co-authors
- Yuan‐Jian LiJie DuYunjiao LiWenqun LiZhenjiang HeNicholas W. MorrellJun YangYing Li
- Journals
- European Journal of Pharmacology (6 papers)PLoS ONE (4 papers)Canadian Journal of Physiology and Pharmacology (4 papers)Vascular Pharmacology (3 papers)Acta Pharmacologica Sinica (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaohui Li
127 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 141
- Pulmonary and Respiratory Medicine 739
- Cancer Research 287
- Cardiology and Cardiovascular Medicine 374
- Molecular Biology 898
- Immunology 270
Countries citing papers authored by Xiaohui Li
This map shows the geographic impact of Xiaohui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Li more than expected).
Fields of papers citing papers by Xiaohui Li
This network shows the impact of papers produced by Xiaohui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Li. The network helps show where Xiaohui Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaohui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 49 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 33 | |
| 11 | 2020 | 15 | |
| 12 | 2018 | 19 | |
| 13 | 2016 | 38 | |
| 14 | 2016 | 15 | |
| 15 | 2015 | 15 | |
| 16 | 2015 | 85 | |
| 17 | 2014 | 25 | |
| 18 | 2012 | 18 | |
| 19 | Recommendation Algorithm of Item Ratings Prediction Based on Cloud Model | 2010 | 3 |
| 20 | 2009 | 1 |
About Xiaohui Li
Xiaohui Li is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Nephrology, Biochemistry and Pharmacology, having authored 134 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (36 papers), Advancements in Battery Materials (9 papers), Renin-Angiotensin System Studies (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Peptidase Inhibition and Analysis (7 papers), Nitric Oxide and Endothelin Effects (6 papers), MicroRNA in disease regulation (6 papers) and Advanced Battery Materials and Technologies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (739 citations), Cancer Research (287 citations), Cardiology and Cardiovascular Medicine (374 citations), Molecular Biology (898 citations) and Immunology (270 citations). Xiaohui Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuan‐Jian Li, Jie Du, Yunjiao Li, Wenqun Li, Zhenjiang He, Nicholas W. Morrell, Jun Yang, Ying Li, Junchao Zheng and Ying Li. Their work appears in journals such as European Journal of Pharmacology, PLoS ONE, Canadian Journal of Physiology and Pharmacology, Vascular Pharmacology and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.